Target intelligence / Profile preview

Inflammatory and Viral Replication Signaling Pathways

Molecular classification
Other
01

Overview

"Inflammatory and viral replication signaling pathways" describe interconnected cellular signaling networks—such as the Toll-like receptor (TLR), Interferon (IFN), Janus kinase-signal transducers and activators of transcription (JAK-STAT), mitogen-activated protein kinase (MAPK), nuclear factor kappa B (NF-κB), and stimulator of interferon genes (STING) pathways—that sense viral infection, coordinate immune responses, induce inflammatory mediators, and regulate apoptosis and antiviral defense. Dysregulation of these pathways can result in severe immunopathology (such as cytokine storm in COVID-19 and sepsis), while viral pathogens often evolve mechanisms to evade, suppress, or hijack these responses to favor their replication. Because these signaling cascades are crucial for determining infection outcomes, many of their constituent molecular components are individually considered drug targets in immunology and infectious disease—it is therefore important to specify the particular molecule to discuss true drug targeting or therapeutic intervention.

Other names
Inflammatory signaling pathwaysViral replication signaling pathwaysHost antiviral signaling pathwaysImmunoinflammatory signaling networks
02

Mechanism of action

Inhibition of cytokine production (e.g., blocking IL-6, TNF-α pathways); Suppression of kinase activity (JAK inhibitors, MAPK inhibitors); Inhibition of transcription factor activation (e.g., NF-κB inhibitors); Downregulation of inflammatory gene expression

03

Biological functions

Immune responseSignal transductionApoptosisInflammationCell proliferationCell death
04

Disease associations

InfectionInflammationCancerSepsisOther immune-related diseases
05

Safety considerations

Immunosuppression/increased infection risk (when suppressing these pathways)Cytokine release syndrome (overactivation)Organ dysfunction/failure (from dysregulated inflammation)Autoimmunity (with inappropriate regulation)
06

Interacting drugs

Corticosteroids (e.g., dexamethasone — broad immunosuppression)

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)Interferon-beta (IFN-β)Various ISGs (interferon-stimulated genes)

Beyond the preview

Go deeper on Inflammatory and Viral Replication Signaling Pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory and Viral Replication Signaling Pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call